Review Article
Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
Table 2
Dysregulated lncRNAs in HCC.
| ā | LncRNA | Target | Expression | Reference |
| Li et al. | LncRNA DCST1-AS1 | mTOR pathway | Upregulated | [60] | Chen et al. | LncRNA OGFRP1 | mTOR pathway | Upregulated | [61] | Guo et al. | LncRNA TMPO-AS1 | FOXK1 | Upregulated | [62] | Peng et al. | LncRNA MALAT1 | PI3k3ā² noncoding region | Upregulated | [63] | Malakar et al. | LncRNA MALAT1 | TCF7L2 | Upregulated | [64] | Ye et al. | LncRNA AK023948 | mTOR pathway | Upregulated | [65] | Wei et al. | LncRNA HAGLROS | MiR-5059/AGLROS axis | Upregulated | [66] | Zheng et al. | LncRNA CDKN2B-AS1 | Let-7c-5p/NAP1L1 axis | Upregulated | [67] | Zhong et al. | LncRNA SNHG16 | p62 | Upregulated | [68] | Han et al. | LncRNA CASC11 | PTEN | Upregulated | [69] | Sun et al. | LncRNA DUXAP10 | GRP39 | Upregulated | [70] | Liu et al. | LncRNA PICSAR | MiR-588 | Upregulated | [71] | Shu et al. | LncRNA LINC00680 | AKT3 | Upregulated | [72] | Xin et al. | LncRNA HULC | PTEN | Downregulated | [73] |
|
|